More on CAMP
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $4.09 |
|
|||
| Open | $4.09 | ||||
| 52 Wk High | $21.34 | ||||
| 52 Wk Low | $12.13 | ||||
| Day High | $4.44 | ||||
| Day Low | $4.00 | ||||
| P/E | 3.02 | ||||
| EPS | $1.33 | ||||
| Volume | 60,028 | ||||
- CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- CAMP4 Therapeutics reports seizure improvements in preclinical study
- CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder
- Calamp Corp. (CAMP) Misses Q1 EPS by 3c
- CAMP4 Reports First Quarter 2026 Financial Results and Corporate Highlights
- CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation
- CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Rodman & Renshaw Starts CAMP4 Therapeutics Corp (CAMP) at Buy
- Form 4 Camp4 Therapeutics Corp For: Apr 01 Filed by: Tardiff Daniel
- Form 4 Camp4 Therapeutics Corp For: Apr 01 Filed by: Maricich Yuri
Entities mentioned with CAMP
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- After-Hours Movers | View Related Stories »
- JPMorgan | View Related Stories »
- Canaccord Genuity | View Related Stories »
- 13G | View Related Stories »
- Pre Market Movers | View Related Stories »
- Show More...
